Non‐Steroidal Anti‐Inflammatory Drugs After Abdominal Surgery: An Umbrella Review of Existing Evidence
ANZ Journal of Surgery · 2026
DOI: 10.1111/ans.70468 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift ANZ Journal of Surgery, 2026. Verfasst von Mikolaj R Kowal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Leeds Institute of Medical Research, University of Leeds, Leeds, UK. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Non-Steroidal, Postoperative Pain, Abdomen. Die Arbeit nennt 43 Literaturangaben. Gefördert von: National Institute for Health and Care Research, Bowel Cancer UK.
Abstract (Originalsprache)
Background
Multi‐modal analgesia is recommended for enhanced recovery after colorectal and abdominal surgery. Previous reviews have reported highly discordant observations around the benefits and risks of non‐steroidal anti‐inflammatory drugs (NSAIDs). This umbrella review aimed to provide a recommendation based on the best available evidence.
Methods
A systematic search was performed for reviews exploring benefits and risks of NSAIDs after abdominal surgery. The quality of reviews was assessed using the AMSTAR‐2 tool. Outcomes of interest comprised clinical efficacy (pain, opioid consumption, return of gut function) and safety (intestinal bleeding, anastomotic leak, acute kidney injury). The presence of discordant conclusions across reviews was investigated using the Jadad decision algorithm to determine the best available evidence.
Results
Twenty‐seven reviews were included, reporting evidence for pain ( n = 10/27), opioid‐consumption ( n = 11/27), gut function ( n = 4/27), bleeding ( n = 1/27), anastomotic leak ( n = 13/27), and acute kidney injury ( n = 2/27). The quality of all reviews was ‘critically low’. The reviews were concordant in showing that NSAIDs reduce pain, opioid consumption, and time to gut recovery. Studies reporting anastomotic leak after colorectal surgery were highly discordant. The best available evidence showed an increased risk of anastomotic leak with non‐selective NSAIDs, but not convincingly for COX‐2 inhibitors.
Conclusion
NSAIDs after abdominal surgery reduce pain, opioid consumption, and the time to gut recovery. In the context of colorectal surgery, non‐selective NSAIDs may increase the risk of anastomotic leak, but this is based on low quality data. Their use should be limited to selective NSAIDs until robust evidence is available to guide decision‐making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
- Royal Hallamshire Hospital, Sheffield, UK.
ORCID-Profile: Mikolaj R Kowal, Anna Nicholls, David G Jayne
Förderung
- National Institute for Health and Care Research
- Bowel Cancer UK
Zitieren
APA
Kowal, M. R., Nicholls, A., Jayne, D. G., & Chapman, S. J. (2026). Non‐Steroidal Anti‐Inflammatory Drugs After Abdominal Surgery: An Umbrella Review of Existing Evidence. ANZ Journal of Surgery. https://doi.org/10.1111/ans.70468
Vancouver
Kowal MR, Nicholls A, Jayne DG, Chapman SJ. Non‐Steroidal Anti‐Inflammatory Drugs After Abdominal Surgery: An Umbrella Review of Existing Evidence. ANZ Journal of Surgery. 2026. doi:10.1111/ans.70468
BibTeX
@article{Kowal2026,
author = {Kowal, Mikolaj R and Nicholls, Anna and Jayne, David G and Chapman, Stephen J},
title = {Non‐Steroidal Anti‐Inflammatory Drugs After Abdominal Surgery: An Umbrella Review of Existing Evidence},
journal = {ANZ Journal of Surgery},
year = {2026},
doi = {10.1111/ans.70468}
}
EUVIMED